Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR). This evidence concerns the gene BPTF and pancreatic ductal adenocarcinoma.